Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SRI - US86183P1021 - Common Stock

5.55 USD
+0.07 (+1.28%)
Last: 11/21/2025, 8:04:00 PM
5.46 USD
-0.09 (-1.62%)
After Hours: 11/21/2025, 8:04:00 PM
Fundamental Rating

2

SRI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 82 industry peers in the Automobile Components industry. SRI may be in some trouble as it scores bad on both profitability and health. SRI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SRI has reported negative net income.
In the past year SRI had a positive cash flow from operations.
In the past 5 years SRI reported 4 times negative net income.
Of the past 5 years SRI 4 years had a positive operating cash flow.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.07%, SRI is doing worse than 82.93% of the companies in the same industry.
Looking at the Return On Equity, with a value of -12.76%, SRI is doing worse than 76.83% of the companies in the same industry.
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

SRI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 20.98%, SRI is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
SRI's Gross Margin has declined in the last couple of years.
SRI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.98%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

SRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRI has more shares outstanding
The number of shares outstanding for SRI has been increased compared to 5 years ago.
The debt/assets ratio for SRI is higher compared to a year ago.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.32 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SRI (2.32) is worse than 60.98% of its industry peers.
SRI has a debt to FCF ratio of 7.28. This is a slightly negative value and a sign of low solvency as SRI would need 7.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.28, SRI is doing worse than 67.07% of the companies in the same industry.
SRI has a Debt/Equity ratio of 0.68. This is a neutral value indicating SRI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.68, SRI is not doing good in the industry: 76.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Altman-Z 2.32
ROIC/WACCN/A
WACC9.31%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SRI has a Current Ratio of 2.13. This indicates that SRI is financially healthy and has no problem in meeting its short term obligations.
SRI's Current ratio of 2.13 is fine compared to the rest of the industry. SRI outperforms 78.05% of its industry peers.
SRI has a Quick Ratio of 1.33. This is a normal value and indicates that SRI is financially healthy and should not expect problems in meeting its short term obligations.
SRI has a better Quick ratio (1.33) than 79.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.33
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

SRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -383.33%.
SRI shows a decrease in Revenue. In the last year, the revenue decreased by -4.92%.
SRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.71% yearly.
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%

3.2 Future

Based on estimates for the next years, SRI will show a very strong growth in Earnings Per Share. The EPS will grow by 59.96% on average per year.
Based on estimates for the next years, SRI will show a small growth in Revenue. The Revenue will grow by 1.18% on average per year.
EPS Next Y9.74%
EPS Next 2Y59.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.93%
Revenue Next 2Y1.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

SRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 21.13 indicates a rather expensive valuation of SRI.
67.07% of the companies in the same industry are cheaper than SRI, based on the Price/Forward Earnings ratio.
SRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 21.13
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRI indicates a slightly more expensive valuation: SRI is more expensive than 60.98% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SRI is valued cheaper than 95.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.61
EV/EBITDA 10.08
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRI does not grow enough to justify the current Price/Earnings ratio.
SRI's earnings are expected to grow with 59.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SRI!.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (11/21/2025, 8:04:00 PM)

After market: 5.46 -0.09 (-1.62%)

5.55

+0.07 (+1.28%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners92.61%
Inst Owner Change-7.4%
Ins Owners2.26%
Ins Owner Change0%
Market Cap155.46M
Revenue(TTM)874.36M
Net Income(TTM)-32.04M
Analysts84
Price Target16.32 (194.05%)
Short Float %0.57%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)1.3%
Max Revenue beat(2)1.8%
Revenue beat(4)3
Avg Revenue beat(4)0.84%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.51%
Revenue beat(12)7
Avg Revenue beat(12)0.72%
Revenue beat(16)11
Avg Revenue beat(16)3.35%
PT rev (1m)0%
PT rev (3m)14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.13
P/S 0.18
P/FCF 6.61
P/OCF 3.5
P/B 0.62
P/tB 0.9
EV/EBITDA 10.08
EPS(TTM)-0.87
EYN/A
EPS(NY)0.26
Fwd EY4.73%
FCF(TTM)0.84
FCFY15.13%
OCF(TTM)1.59
OCFY28.58%
SpS31.22
BVpS8.97
TBVpS6.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.98%
FCFM 2.69%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score5
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Debt/EBITDA 6.29
Cap/Depr 62.27%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion 164.3%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.33
Altman-Z 2.32
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y9.74%
EPS Next 2Y59.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%
Revenue Next Year-4.93%
Revenue Next 2Y1.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-152.66%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year178.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y295.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.75%
OCF growth 3YN/A
OCF growth 5Y14.27%

STONERIDGE INC / SRI FAQ

What is the fundamental rating for SRI stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRI.


What is the valuation status for SRI stock?

ChartMill assigns a valuation rating of 3 / 10 to STONERIDGE INC (SRI). This can be considered as Overvalued.


How profitable is STONERIDGE INC (SRI) stock?

STONERIDGE INC (SRI) has a profitability rating of 1 / 10.


How financially healthy is STONERIDGE INC?

The financial health rating of STONERIDGE INC (SRI) is 5 / 10.